News

Published on 10 May 2024 on Insider Monkey via Yahoo Finance

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript


Article preview image

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript May 10, 2024. CHRS isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to Coherus BioSciences, Inc. First Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any backward notes. After the speaker's remarks, there will be a question-and-answer session. [Operator Instructions] I would now like to turn the conference over to Jamie Taylor, Head of Investor Relations. Please go ahead.

NASDAQ.CHRS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
We Think Some Shareholders May Hesitate To Increase Coherus BioSciences, Inc.'s (NASDAQ:CHRS) CEO...

Key Insights Coherus BioSciences to hold its Annual General Meeting on 29th of MaySalary of US$98...

Simply Wall St. via Yahoo Finance 23 May 2024

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript May 10, 2024. CHRS isn't...

Insider Monkey via Yahoo Finance 10 May 2024

When Can We Expect A Profit From Coherus BioSciences, Inc. (NASDAQ:CHRS)?

With the business potentially at an important milestone, we thought we'd take a closer look at Co...

Simply Wall St. via Yahoo Finance 8 May 2024

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript March 13, 2024 Coherus B...

Insider Monkey via Yahoo Finance 16 Mar 2024

Coherus BioSciences Inc (CHRS) Reports Growth in Net Revenue for Q4 and Full Year 2023 Despite ...

Net Revenue: Coherus BioSciences Inc (NASDAQ:CHRS) reported a significant increase in net revenue...

GuruFocus.com via Yahoo Finance 13 Mar 2024

In the wake of Coherus BioSciences, Inc.'s (NASDAQ:CHRS) latest US$49m market cap drop,...

Key Insights Institutions' substantial holdings in Coherus BioSciences implies that they have sig...

Simply Wall St. via Yahoo Finance 5 Mar 2024

Analysts Are More Bearish On Coherus BioSciences, Inc. (NASDAQ:CHRS) Than They Used To Be

The latest analyst coverage could presage a bad day for Coherus BioSciences, Inc. (NASDAQ:CHRS), ...

Simply Wall St. via Yahoo Finance 27 Jan 2024

Coherus (CHRS) Stock Rallies on FDA Nod for Udenyca Onbody

Shares of Coherus BioSciences, Inc. CHRS were up 23.4% on Dec 27 after the company announced that...

Zacks via Yahoo Finance 28 Dec 2023

Why Coherus BioSciences Stock Is Climbing Today - Coherus BioSciences (NASDAQ:CHRS)

Coherus BioSciences, Inc. CHRS shares are trading higher Wednesday after the company announced th...

Benzinga 27 Dec 2023

Coherus BioSciences And Other Big Stocks Moving Higher In Wednesday’s Pre-Market Session - Bitfarms...

U.S. stock futures were slightly lower this morning, with the Dow Jones futures falling around 5 ...

Benzinga 27 Dec 2023